dr. kim addresses concerns about hyperprogression in nsclc
Published 6 years ago • 196 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
0:59
dr. denham on hyperprogression in patients with nsclc
-
1:05
dr. kim on role of frontline immunotherapy in advanced hcc
-
1:16
dr. kim on the safety of immune checkpoint inhibition in surgical patients with lung cancer
-
1:21
dr. kim on the need for eapathways as a decision-making tool
-
1:22
dr. kim on immunotherapy in crc
-
1:44
immunotherapy: how t cells fight cancer
-
1:05
edward kim, md, on anti-pd-l1/pd-1 combination therapies in treatment of lung cancer
-
6:44
what oncology's figured out about the ehr | dr. ed kim of atrium health
-
1:01
david j. mcconkey, phd, on treating bladder cancer with checkpoint inhibitors
-
2:10
dr. jean kim
-
1:52
new ai technology detects more cancer patients treatable with immunotherapy
-
1:18
dr. kim on the evolving treatment landscape of advanced hcc
-
14:02
using smart particles to cure cancer | carolyn d. runowicz and sakhrat khizroev | tedxfiu
-
1:35
artificial intelligence revolutionizes diagnosis in one of the world s deadliest cancers
-
6:38
about dr. kim
-
22:50
breast cancer risk and endocrine disrupting chemicals (edcs): what are edcs? | breast cancer uk
-
3:41
a future immune to cancer, with dr. drew pardoll
-
2:41
dr. roy herbst describes the efficacy of immune checkpoint inhibitors